(Q44420267)

English

A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study

scientific article published in May 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Richard K Parrish

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Paul Palmberg

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Wang-Pui Sheu

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

XLT Study Group

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

American Journal of Ophthalmology

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

135

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

688-703

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Prostaglandin analog treatment of glaucoma and ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Bimatoprost: a member of a new class of agents, the prostamides, for glaucoma management

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sections

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Ocular hypotensive mechanism of topical isopropyl unoprostone, a novel prostaglandin metabolite-related drug, in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

A comparison of intraocular pressure-lowering effect of prostaglandin F2 -alpha analogues, latanoprost, and unoprostone isopropyl

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

A comparison of the intraocular pressure-lowering effect of 0.5% timolol maleate and the docosanoid derivative of a PGF2 alpha metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP : a 3-month clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Intraocular pressure over 24 hours after single-dose administration of latanoprost 0.005% in healthy volunteers. A randomized, double-masked, placebo controlled, cross-over single center study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Investigation of parameters influencing intraocular pressure increases during sleep.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

A pooled-data analysis of three randomized, double-masked, six-month clinical studies comparing the intraocular pressure reducing effect of latanoprost and timolol.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900098-9

7 January 2021

Identifiers

10.1016/S0002-9394(03)00098-9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44420267&oldid=2022512830"